当前位置: 首页 > 期刊 > 《中国医药科学》 > 2022年第2期
编号:117965
基于肠道菌群探讨清肝化痰法干预原发性高血压的作用机制
http://www.100md.com 2022年5月5日 中国医药科学 2022年第2期
     赵睿学 荆鲁

    [摘要]肝火亢盛夹痰是原发性高血压的重要病机关键,临床应用清肝化痰法治疗原发性高血压多能够取得良好疗效,但作用机制尚未完全阐明。近年来,大量研究证实,肠道菌群在原发性高血压的发生发展过程中起着不可忽视的作用。现代中医药理论研究表明,肝、脾功能失常与肠道微生物菌群失调密切相关。本文阐述了清肝化痰法治疗原发性高血压的现代理论基础,并基于肠道菌群理论探索清肝化痰方药治疗高血压效应机制,以期找到治疗高血压的新思路和研究方向。

    [关键词]原发性高血压;肠道菌群;清肝化痰法;机制

    [中图分类号]R259? [文献标识码]A? [文章编号]2095-0616(2022)02-0029-05

    Discussion on the mechanism of intervention of liver-clearing and phlegm-resolving therapy on essential hypertension based on intestinal flora

    ZHAO Ruixue1? JING Lu2

    l.Dongzhimen Hospital,Beijing University of Chinese Medicine,Beijing 100029,China;2.Eye Hospital of Chinese Academy of Chinese Medical Sciences,Beijing 100040,China

    [Abstract] The overabundant liver-fire and phlegm syndrome is the key to the pathogenesis of essential hypertension. Clinical application of liver-clearing and phlegm-resolving therapy can achieve good results in treating essential hypertension,but the mechanism has not been fully clarified. In recent years,a large number of studies have confirmed that intestinal flora plays an important role in the occurrence and development of essential hypertension. Modern theoretical researches of traditional Chinese medicine show that the dysfunction of liver and spleen is closely related to the imbalance of intestinal microbial flora. In this paper ......

您现在查看是摘要页,全文长 16684 字符